Delivery Order SPE2DB22D9207-SPE2DB25FH5BD
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at approximately $17,000 by the Defense Logistics Agency (DLA) on July 18, 2025. The contract, which carries no set-aside designation, covers the supply of Somatuline Depot 120 mg/0.5 ml injectable medication with an ultimate completion date of August 8, 2025. This delivery order is issued under DMS Pharmaceutical Group's larger...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $21,222.80 by the Defense Logistics Agency on August 11, 2025. The order covers the supply of Somatuline Depot 120 mg/0.5 ml injectable medication, with an ultimate completion date of September 2, 2025. This delivery order was issued without a set-aside designation, and the place of performance is located in Park Ridge,...
- The Defense Logistics Agency awarded a $25.5K delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Somatuline Depot 120 mg/0.5 ml injections. The order, issued on April 24, 2025, with an ultimate completion date of May 15, 2025, represents a firm fixed-price delivery order with no set-aside designation. This award is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order for $15,877.80 under an indefinite delivery contract with the Defense Logistics Agency to supply Somatuline 120mg injectable pharmaceutical products. The delivery order was awarded on November 2, 2023 and requires completion by November 2, 2023. DMS Pharmaceutical Group will provide the injectable medications to Defense Logistics Agency Troop Support Medical facilities located in Park Ridge, Illinois. As a...
- This is a $6,436.92 firm fixed-price delivery order awarded by the Defense Logistics Agency Troop Support Medical to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of Somatuline 120mg pharmaceutical products, with a completion date of January 30, 2024. The contract has no set-aside designation. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that provides a wide range of branded and generic...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order, valued at $5,363.85, is for the supply of the pharmaceutical product Somatulin-Depot 60mg, with an ultimate completion date of May 6, 2024. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at twenty-six thousand four hundred sixty-three dollars by the Defense Logistics Agency Troop Support Medical. This order was issued against an existing indefinite delivery contract held by DMS Pharmaceutical Group to supply pharmaceutical items and medical products to various military treatment facilities supported by the Defense Logistics Agency. Under this particular order, DMS Pharmaceutical Group will...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to the prime contractor DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract, valued at $21,222.80, is for the pharmaceutical product SOMATULINE DEPOT 120 MG/0.5 ML 0.5ML. The contract is a firm fixed-price delivery order with a completion date of February 26, 2025. DMS Pharmaceutical Group Inc. has a larger Indefinite Delivery Contract (IDC) with the DLA...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $12,873.80 award is for the supply of SOMATULINE DEPOT 120 MG/0.5 ML 0.5ML, a specialized pharmaceutical product, with an ultimate completion date of January 2, 2025. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $6,541.47 on May 30, 2025, for the supply of Sandostatin LAR Depot 10 mg kits. The award was issued without a set-aside designation and is funded through the Medical Supply Chain, a defense-oriented federal agency. This delivery order is set to be completed by June 2, 2025, with performance taking place at the awardee's...
- SPE2DB22D9207Indefinite Delivery Contract
- SPE2DB22D9207-SPE2DB25FH5BDDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was awarded a delivery order valued at $16,978.24 by the Defense Logistics Agency (DLA) on June 25, 2025, for the supply of Somatuline Depot 120 mg/0.5 ml injections. This firm fixed-price delivery order, which carries an ultimate completion date of July 17, 2025, represents a direct fulfillment requirement under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA under the SPE2DB program. The delivery order was issued without a set-aside designation, and the place of performance is Park Ridge, Illinois. This award exemplifies the critical role DMS Pharmaceutical Group plays within the federal pharmaceutical supply chain, leveraging its position as a preferred vendor under the DLA's $500 million indefinite delivery contract to support military healthcare facilities nationwide. Somatuline Depot, a specialized pharmaceutical product used in medical treatment protocols, will be distributed to support Department of Defense healthcare operations. The company's consistent success in securing delivery orders for diverse pharmaceutical products—ranging from oncology treatments to vaccines and specialty injections—underscores its established capability to meet the complex procurement requirements of federal health systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.0k | 6/25/25 |